Your browser doesn't support javascript.
loading
AS602801 Sensitizes Ovarian Cancer Stem Cells to Paclitaxel by Down-regulating MDR1.
Yamamoto, Masahiro; Suzuki, Shuhei; Togashi, Keita; Sanomachi, Tomomi; Seino, Shizuka; Kitanaka, Chifumi; Okada, Masashi.
Afiliação
  • Yamamoto M; Department of Molecular Cancer Science, Yamagata University School of Medicine, Yamagata, Japan masahiro@med.id.yamagata-u.ac.jp m-okada@med.id.yamagata-u.ac.jp.
  • Suzuki S; Department of Molecular Cancer Science, Yamagata University School of Medicine, Yamagata, Japan.
  • Togashi K; Department of Clinical Oncology, Yamagata University School of Medicine, Yamagata, Japan.
  • Sanomachi T; Department of Molecular Cancer Science, Yamagata University School of Medicine, Yamagata, Japan.
  • Seino S; Department of Ophthalmology, Yamagata University School of Medicine, Yamagata, Japan.
  • Kitanaka C; Department of Molecular Cancer Science, Yamagata University School of Medicine, Yamagata, Japan.
  • Okada M; Department of Clinical Oncology, Yamagata University School of Medicine, Yamagata, Japan.
Anticancer Res ; 39(2): 609-617, 2019 Feb.
Article em En | MEDLINE | ID: mdl-30711936
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Pirimidinas / Células-Tronco Neoplásicas / Paclitaxel / Benzotiazóis Limite: Female / Humans Idioma: En Revista: Anticancer Res Ano de publicação: 2019 Tipo de documento: Article País de publicação: Grécia
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Pirimidinas / Células-Tronco Neoplásicas / Paclitaxel / Benzotiazóis Limite: Female / Humans Idioma: En Revista: Anticancer Res Ano de publicação: 2019 Tipo de documento: Article País de publicação: Grécia